Clinical Drug Experience Knowledgebase

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (1 trial)

diphtheria antitoxin (dat) (1 trial)

DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine (Pediarix) (4 trials)

enoxaparin (lovenox) (1 trial)

Inactivated polio virus - Enhanced (IPOL) (2 trials)

measles-rubella vaccine (M-R-Vax) (2 trials)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (2 trials)

apixaban (eliquis) (1 trial)

diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (2 trials)

haemophilus influenzae type b conjugate vaccine (HibTITER) (3 trials)

hepatitis b vaccine (recombinant) (Recombivax) (7 trials)

hydroxychloroquine (plaquenil) (1 trial)

inactivated influenza vaccine (3 trials)

inactivated SARS-Cov-2 vaccine (2 trials)

pqed typhoid conjugate vaccine (1 trial)

rotavirus rv3 vaccine (1 trial)

sars-cov-2 protein subunit recombinant vaccine PT Biopharma (7 trials)

typhoid vi polysaccharide vaccine (Typhim Vi) (3 trials)

vi-dt typhoid conjugate vaccine (4 trials)

bcg tice (1 trial)

monovalent oral polio vaccines (mopv1) (MOPV1) (1 trial)

novel oral polio vaccine type 1 (nopv1) (1 trial)

novel oral polio vaccine type 2 (nopv2) (1 trial)

novel oral polio vaccine type 3 (nopv3) (1 trial)

COVID-19 convalescent plasma (1 trial)

dipropyltryptamine (1 trial)

hib/prp-t vaccine (Hiberix) (1 trial)

rotavirus (bio farma) vaccine (1 trial)